Compound ID | 1342
Class: Macrolide (azalide)
| Spectrum of activity: | Gram-positive & Gram-negative |
| Institute where first reported: | Pilva, Zagreb, Croatia |
| Year first mentioned: | 1980 |
| Highest development stage: | Approved by FDA in 2005 |
| Development status: | Approved |
| Reason dropped: | Other formulations were discontinued |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/447043 |
| Guide to Pharmacology: | azithromycin |
| Citation: | https://pubmed.ncbi.nlm.nih.gov/1280567/ |